Literature DB >> 17235706

The role of probiotics in inflammatory bowel disease.

Jennifer L Jones1, Amy E Foxx-Orenstein.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17235706     DOI： 10.1007/s10620-006-9225-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  42 in total

Review 1.  Gut flora in health and disease.

Authors:  Francisco Guarner; Juan-R Malagelada
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 2.  Probiotics and inflammatory bowel disease: is there a scientific rationale?

Authors:  F Shanahan
Journal:  Inflamm Bowel Dis       Date:  2000-05       Impact factor: 5.325

Review 3.  Probiotics: what are they? What are their effects on gut physiology?

Authors:  Jean Fioramonti; Vassilia Theodorou; Lionel Bueno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-10       Impact factor: 3.043

4.  Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.

Authors:  Arnoldo J Riquelme; Mario A Calvo; Ana M Guzmán; María S Depix; Patricia García; Carlos Pérez; Marco Arrese; Jaime A Labarca
Journal:  J Clin Gastroenterol       Date:  2003-01       Impact factor: 3.062

5.  Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.

Authors:  Minna K Salminen; Soile Tynkkynen; Hilpi Rautelin; Maija Saxelin; Martti Vaara; Petri Ruutu; Seppo Sarna; Ville Valtonen; Asko Järvinen
Journal:  Clin Infect Dis       Date:  2002-10-21       Impact factor: 9.079

6.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Authors:  A Macpherson; U Y Khoo; I Forgacs; J Philpott-Howard; I Bjarnason
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function.

Authors:  Henri Braat; Jan van den Brande; Erik van Tol; Daan Hommes; Maikel Peppelenbosch; Sander van Deventer
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

8.  Saccharomyces boulardii in maintenance treatment of Crohn's disease.

Authors:  M Guslandi; G Mezzi; M Sorghi; P A Testoni
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

9.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

Review 10.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682
View more
  7 in total

1.  A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Fatemeh Rahimi; Behzad Elahi; Saeed Derakhshani; Mohammad Vafaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

Review 2.  Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Authors:  M-I Torres; A Rios
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

3.  The emerging therapeutic role of probiotics in inflammatory bowel disease.

Authors:  Matthew Chandler; Eric Wollins; Anastasia Toles; Marie Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-09

Review 4.  The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review.

Authors:  Ghada Araji; Julian Maamari; Fatima Ali Ahmad; Rana Zareef; Patrick Chaftari; Sai-Ching Jim Yeung
Journal:  J Immunother Precis Oncol       Date:  2021-11-16

5.  On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials.

Authors:  Behzad Elahi; Shekoufeh Nikfar; Saeed Derakhshani; Mohammad Vafaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-10-17       Impact factor: 3.199

6.  Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production.

Authors:  Riina-A Kekkonen; Elina Kajasto; Minja Miettinen; Ville Veckman; Riitta Korpela; Ilkka Julkunen
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

7.  Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study.

Authors:  John Sampalis; Eliofotisti Psaradellis; Emmanouil Rampakakis
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.